Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 9, 2004, Pages 4708-4715

  Williams, Maro R I ^a   Dawood, Tye ^a   Ling, Shanhong ^a,b   Dai, Aozhi ^a,b   Lew, Robert ^a   Myles, Kathy ^a   Funder, John W ^a,c   Sudhir, Krishnankutty ^a,d   Komesaroff, Paul A ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; ESTROGEN RECEPTOR; FLUTAMIDE; FULVESTRANT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE 1; PRASTERONE; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRACHIAL ARTERY; CATTLE; CELL FUNCTION; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG MECHANISM; ENDOTHELIUM CELL; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPEREMIA; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; LIPID BLOOD LEVEL; NONHUMAN; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; ANIMALS; BRACHIAL ARTERY; CATTLE; CELL DIVISION; CELLS, CULTURED; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; ENDOTHELIAL CELLS; ESTRADIOL; FEMALE; FLUTAMIDE; HUMANS; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; SKIN; TESTOSTERONE;

ANIMALIA; BOS TAURUS;

EID: 4544302443     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031560     Document Type: Article

References (48)

1. Orentreich N, Brind JL, Rizer RL, Vogelman JH 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551-555
2. Hornsby PJ 1995 Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Ann NY Acad Sci 774:29-46
3. LaCroix AZ, Yano K, Reed DM 1992 Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men. Circulation 86:1529-1535
4. Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H 1992 Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 75:1002-1004
5. Haning Jr RV, Carlson IH, Flood CA, Hackett RJ, Longcope C 1991 Metabolism of dehydroepiandrosterone sulfate (DS) in normal women and women with high DS concentrations. J Clin Endocrinol Metab 73:1210-1215
6. Haning Jr RV, Flood CA, Hackett RJ, Loughlin JS, McClure N, Longcope C 1991 Metabolic clearance rate of dehydroepiandrosterone sulfate, its metabolism to testosterone, and its intrafollicular metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone in vivo. J Clin Endocrinol Metab 72:1088-1095
7. i2,3. J Biol Chem 277:21379-21388
8. Alexandersen P, Haarbo J, Christiansen C 1996 The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 125: 1-13
9. Beer NA, Jakubowicz DJ, Matt DW, Beer RM, Nestler JE 1996 Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in men. Am J Med Sci 311:205-210
10. Eich DM, Nestler JE, Johnson DE, Dworkin GH, Ko D, Wechsler AS, Hess ML 1993 Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Circulation 87:261-269
11. Araneo, B, Dowell T, Woods ML, Daynes R, Judd M, Evans T 1995 DHEAS as an effective vaccine adjuvant in elderly humans. Proof-of-principle studies. Ann NY Acad Sci 774:232-248
12. Evans, TG, Judd ME, Dowell T, Poe S, Daynes RA, Araneo BA 1996 The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly. Vaccine 14:1531-1537
13. Rao MS, Subbarao V, Yeldandi AV, Reddy JK 1992 Inhibition of spontaneous testicular Leydig cell tumor development in F-344 rats by dehydroepiandrosterone. Cancer Lett 65:123-126
14. Young J, Corpechot C, Haug M, Gobaille S, Baulieu EE, Robel P 1991 Suppressive effects of dehydroepiandrosterone and 3β-methyl-androst-5-en- 17-one on attack towards lactating female intruders by castrated male mice. II. Brain neurosteroids. Biochem Biophys Res Commun 174:892-897
15. Flood JF, Roberts E 1988 Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res 448:178-181
16. Melchior CL, Ritzmann RF 1994 Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol Biochem Behav 47:437-441
17. Williams MR, Ling S, Dawood T, Hashimura K, Dai A, Li H, Liu JP, Funder JW, Sudhir K, Komesaroff PA 2002 Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J Clin Endocrinol Metab 87:176-181
18. Clarkson P, Celermajer DS, Powe AJ, Donald AE, Henry RM, Deanfield JE 1997 Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation 96:3378-3383
19. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield JE 1996 Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 334:150-154
20. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE 1992 Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115
21. Wellman GC, Brayden JE, Nelson MT 1996 A proposed mechanism for the cardioprotective effect of oestrogen in women: enhanced endothelial nitric oxide release decreases coronary artery reactivity. Clin Exp Pharmacol Physiol 23:260-266
22. Nuedling S, Kahlert S, Loebbert K, Doevendans PA, Meyer R, Vetter H, Grohe C 1999 17β-Estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc Res 43: 666-674
23. White CR, Shelton J, Chen SJ, Darley-Usmar V, Allen L, Nabors C, Sanders PW, Chen YF, Oparil S 1997 Estrogen restores endothelial cell function in an experimental model of vascular injury. Circulation 96:1624-1630
24. Gilligan DM., Badar DM, Panza JA, Quyyumi AA, Cannon RO 1994 Acute vascular effects of estrogen in postmenopausal women. Circulation 90:786-791
25. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK, Schnaper HW 1995 Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91:755-763
26. Somjen D, Kohen F, Jaffe A, Amir-Zaltsman Y, Knoll E, Stern N 1998 Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells. Hypertension 32:39-45
27. Chou, TM, Sudhir K, Hutchison SJ, Ko E, Amindon TM, Collins P, Chatterjee K 1996 Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 94:2614-2619
28. de Dios ST, Hannan KM, Dilley RJ, Hill MA, Little PJ 2001 Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells. J Diabetes Complications 15:120-127
29. Edgell CJ, McDonald CC, Graham JB 1983 Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80:3734-3737
30. Komesaroff PA, Black CV, Westerman RA 1998 A novel, nongenomic action of estrogen on the cardiovascular system. J Clin Endocrinol Metab 83:2313-2316
31. Ebeling P, Koivisto VA 1994 Physiological importance of dehydroepiandrosterone. Lancet 343:1479-1481
32. Labrie F, Belanger A, Simard J, Van L-T, Labrie C 1995 DHEA and peripheral androgen and estrogen formation: intracinology. Ann NY Acad Sci 774:16-28
33. Yoneyama A, Kamiya Y, Kawaguchi M, Fujinami T 1997 Effects of dehydroepiandrosterone on proliferation of human aortic smooth muscle cells. Life Sci [Erratum (1997) 60:2155] 60:833-838
34. Saenger P, New M 1977 Inhibitory action of dehydroepiandrosterone (DHEA) on fibroblast growth. Experientia 33:966-967
35. Meikle AW, Dorchuck RW, Araneo BA, Stringham JD, Evans TG, Spruance SL, Daynes RA 1992 The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Mol Biol 42: 293-304
36. McIntosh M, Hausman D, Martin R, Hausman G 1998 Dehydroepiandrosterone attenuates preadipocyte growth in primary cultures of stromal-vascular cells. Am J Physiol 275:E285-E293
37. Zhu X, Li H, Liu JP, Funder JW 1999 Androgen stimulates mitogen-activated protein kinase in human breast cancer cells. Mol Cell Endocrinol 152:199-206
38. Singh M, Setalo Jr G, Guan X, Frail DE, Toran-Allerand CD 2000 Estrogen-induced activation of the mitogen-acrivated protein kinase cascade in the cerebral cortex of estrogen receptor-α knock-out mice. J Neurosci 20:1694-1700
39. Yoshimata T, Yoneyama A, Jin-no Y, Tamai N, Kamiya Y 1999 Effects of dehydroepiandrosterone on mitogen-acrivated protein kinase in human aortic smooth muscle cells. Life Sci 65:431-440
40. Manabe A, Hata T, Yanagihara T, Hashimoto M Yamada Y, Irkoma S, Aoki S, Masumura S, Miyazakin K 1999 Nitric oxide synthesis is increased after dehydroepiandrosterone sulphate administration in term human pregnancy. Hum Reprod 14:2116-2119
41. Chen YF, Meng QC 1991 Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci 48:85-96
42. Worboys S, Kotsopoulos D, Teede H, McGrath B, Davis S 2001 Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab 86:158-161
43. Oudar O, Elger M, Bankir L, Ganten D, Ganten U, Kriz W 1991 Differences in rat kidney morphology between males, females and testosterone-treated females. Ren Physiol Biochem 14:92-102
44. Reckelhoff JF, Zhang H, Granger JP 1998 Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 31:435-439
45. Reckelhoff JF, Zhang H, Srivistiva K, Granger JP 1999 Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 34:920-923
46. Rubanyi GM 1993 The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 22(Suppl 4):S1-S14
47. Palmer RM, Ferrige AG, Moncada S 1987 Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526
48. Palmer RM, Rees DD, Ashton DS, Moncada S 1988 L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 153:1251-1256